Buy FOXO4-DRI (Proxofim) (10mg)

Buy FOXO4-DRI (Proxofim) (10mg)

Buy FOXO4-DRI (Proxofim) (10mg) to access a pioneering peptide used in cellular and molecular research on senescence and apoptosis. FOXO4-DRI, also known as Proxofim, is designed to selectively disrupt the interaction between FOXO4 and p53 in senescent cells, promoting targeted elimination of aging cells while leaving healthy cells intact.

Researchers employ this peptide to explore cellular senescence, age-related tissue dysfunction, and regenerative processes. Its precise mechanism and high specificity make it an invaluable tool for laboratory studies focused on aging biology, molecular pathways, and cellular rejuvenation.

---

Molecular Structure and Composition of Buy FOXO4-DRI (Proxofim) (10mg)

At the molecular level, Buy FOXO4-DRI (Proxofim) (10mg) is a synthetic D-retro-inverso peptide engineered to interfere with FOXO4-p53 binding. Its design enhances stability, resistance to proteolytic degradation, and binding affinity to target senescent cells.

The peptide has a molecular weight of approximately 1.8 kDa, reflecting its small, compact structure, which allows rapid cellular penetration. Lyophilized FOXO4-DRI ensures long-term stability, while reconstitution in sterile water or an appropriate buffer preserves bioactivity for laboratory experiments. Proper storage at -20°C or below is essential for maintaining peptide integrity.

---

Mechanism of Action and Research Significance

FOXO4-DRI functions by disrupting the protein-protein interaction between FOXO4 and p53 in senescent cells. When researchers buy FOXO4-DRI (Proxofim) (10mg), they study how this disruption triggers selective apoptosis in aging cells without affecting proliferating or healthy cells.

This targeted elimination reduces the accumulation of senescent cells, which are known to contribute to tissue dysfunction, chronic inflammation, and age-related disease. Laboratory studies indicate that FOXO4-DRI induces mitochondrial depolarization in senescent cells, initiating apoptosis while sparing surrounding tissues.

By analyzing this mechanism, scientists gain critical insights into cellular aging, senescence-associated signaling, and molecular strategies for rejuvenation and regenerative research.

---

Experimental Applications and Findings

Researchers buy FOXO4-DRI (Proxofim) (10mg) to investigate senolytic effects, tissue rejuvenation, and age-related cellular regulation. Preclinical studies show that this peptide effectively reduces senescent cell populations in vitro and in vivo, improving tissue function and enhancing regenerative capacity.

Laboratory observations reveal that FOXO4-DRI promotes apoptosis selectively in senescent fibroblasts, endothelial cells, and other tissue-specific cell types. This effect is crucial for studies exploring therapeutic strategies for aging-related diseases, metabolic dysfunction, and tissue repair.

ARA-FOXO4-DRI also serves as a benchmark peptide for comparative studies, allowing researchers to differentiate between general cytotoxic agents and targeted senolytic compounds, providing insights into selective cellular elimination and molecular safety profiles.

---

Handling, Storage, and Laboratory Guidelines

To preserve activity, Buy FOXO4-DRI (Proxofim) (10mg) must be stored in a dry, cold environment at -20°C or lower. The lyophilized peptide should be protected from light and moisture. Reconstituted solutions should be aliquoted to prevent repeated freeze–thaw cycles, which may compromise bioactivity.

Researchers use precise measurements and sterile techniques when preparing peptide solutions for experiments. Maintaining detailed documentation of experimental conditions—including concentration, solvent, and incubation parameters—is essential to ensure reproducibility and reliability of results.

---

Comparative Importance in Peptide Research

FOXO4-DRI distinguishes itself from other peptides by its selective senolytic activity and molecular precision. Unlike broad-spectrum apoptotic agents, it specifically targets senescent cells, preserving healthy cells and minimizing off-target effects.

Laboratories frequently use FOXO4-DRI in combination with other regenerative peptides to explore synergistic effects, tissue rejuvenation potential, and age-related molecular pathways. These studies provide valuable insights into senescence biology and enable the development of targeted therapeutic strategies.

---

Conclusion

Buy FOXO4-DRI (Proxofim) (10mg) is a critical peptide for laboratories investigating cellular senescence, targeted apoptosis, and tissue rejuvenation. Its selective disruption of FOXO4-p53 interactions, high stability, and reproducible activity make it an essential tool for aging research, molecular biology, and regenerative studies.

By providing a precise model for eliminating senescent cells, FOXO4-DRI allows researchers to explore innovative strategies for tissue repair, age-related disease intervention, and cellular rejuvenation. Its specificity, potency, and research versatility ensure ongoing relevance in laboratory studies focused on senescence and regenerative biology.

---